Zymeworks Inc.
Customers
1
0 disclosed
Suppliers
0
None disclosed
Largest customer
—
No % disclosed
Named-customer revenue
—
No estimate available
Latest period
Mar 31, 2025
10-Q filed 2025-05-08
Customers 1
Companies ZYME discloses as major customers, as a share of ZYME revenue. 0 active, 1 lapsed.
| Company | % of ZYME revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| GSK GSK plc |
Named | — | 3M 2025-03-31 | — | Lapsed Last seen 2025-03-31 |
10-Q 2025-05-08 |
At March 31, 2025, the maximum exposure to credit risk for accounts receivable was $24,594, 57% of which was from GSK (December 31, 2024: 95% of receivables from Jazz) and all accounts receivable are due within the next 12 months. | ||||||
Alerts are coming
Get an email when ZYME's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.